{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:00:35Z","timestamp":1791230435859,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.atherosclerosis.2014.05.918","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T13:11:18Z","timestamp":1401973878000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment"],"prefix":"10.1016","volume":"235","author":[{"given":"Cho-Kai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Tseng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Kuang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Ming","family":"Jimmy Juang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Pin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juey-Jen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Lee","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00018-011-0633-6","article-title":"Novel therapy for myocardial infarction: can HGF\/Met be beneficial?","volume":"68","author":"Sala","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIR.0b013e31820f2f3e","volume":"123","author":"Wrigt","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1037\/0033-2909.131.2.260","article-title":"Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions","volume":"131","author":"Suls","year":"2005","journal-title":"Psychol Bull"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jacc.2007.09.033","article-title":"Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors","volume":"51","author":"Shen","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2004.09.001","article-title":"Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study","volume":"78","author":"Gorgels","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0895-4356(92)90044-N","article-title":"Long-term use of benzodiazepinesin a Swedish community: an eight-year follow-up","volume":"45","author":"Isacson","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00228-004-0808-2","article-title":"Patterns and correlates of benzodiazepine use in the French general population","volume":"60","author":"Lagnaoui","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/fampra\/cmh309","article-title":"Long-term benzodiazepine users in family practice: differences from short-term users in mental health, coping behaviour and psychological characteristics","volume":"21","author":"Zandstra","year":"2004","journal-title":"Fam Pract"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","article-title":"Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study","volume":"104","author":"Fang","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1377\/hlthaff.22.3.77","article-title":"Does universal health insurance make health care unaffordable? Lessons from Taiwan","volume":"22","author":"Lu","year":"2003","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-8510(96)00877-9","article-title":"Taiwan's 1995 health care reform","volume":"39","author":"Chiang","year":"1997","journal-title":"Health Policy"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diacare.27.7.1605","article-title":"Mortality and causes of death in a national sample of diabetic patients in Taiwan","volume":"27","author":"Tseng","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2011.03.033","article-title":"Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation \u2013 a nation wide database analysis","volume":"217","author":"Lin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0735-1097(01)01109-3","article-title":"Development and validation of the Ontario acute myocardial infarction mortality prediction rules","volume":"37","author":"Tu","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib15","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.90.5.2225","article-title":"Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study","volume":"90","author":"Kawachi","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","article-title":"Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Rosengren","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-3223(95)00136-0","article-title":"Autonomic characteristics of generalized anxiety disorder and worry","volume":"39","author":"Thayer","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0149-7634(03)00003-4","article-title":"Biological mechanisms in the relationship between depression and heart disease","volume":"26","author":"Grippo","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.psy.0000149256.81953.49","article-title":"DS14: standard assessment of negative affectivity, social inhibition, and Type D personality","volume":"67","author":"Denollet","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.64.2.225","article-title":"Negative emotions and 3-year progression of subclinical atherosclerosis","volume":"64","author":"Stewart","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.anclin.2011.09.001","article-title":"Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids","volume":"29","author":"Devlin","year":"2011","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.arbres.2010.05.009","article-title":"Acute hypercapnic respiratory failure in patients with sleep apneas","volume":"46","author":"Sampol","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","article-title":"Decreased heart rate variability and its association with increased mortality after acute myocardial infarction","volume":"59","author":"Kleiger","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib24","first-page":"1364","article-title":"Noninvasive monitoring of the autonomic nervous system and hemodynamics of patients with blunt and penetrating trauma","volume":"65","author":"Colombo","year":"2008","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2125.2008.03185.x","article-title":"Inappropriate benzodiazepine use in older adults and the risk of fracture","volume":"66","author":"van der Hooft","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","article-title":"Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?","volume":"164","author":"Wagner","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2014.05.918_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.158.6.892","article-title":"Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture","volume":"158","author":"Wang","year":"2001","journal-title":"Am J Psychiatry"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:27:24Z","timestamp":1538569644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501401168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S002191501401168X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.918","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}